Join
Live feed
·
PRReleasevia Quantisnow
Aquestive Therapeutics Inc. logo

Aquestive Therapeutics Announces FDA Acceptance of Anaphylm™ NDA Resubmission and PDUFA Goal Date of March 16, 2027

ByQuantisnow·Wall Street's wire, on your screen.
AQST· Aquestive Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AQST (Aquestive Therapeutics Inc.) and more on Quantisnow.